360 related articles for article (PubMed ID: 3950467)
41. Evidence for chronic inflammation as a component of the interstitial lung disease associated with progressive systemic sclerosis.
Rossi GA; Bitterman PB; Rennard SI; Ferrans VJ; Crystal RG
Am Rev Respir Dis; 1985 Apr; 131(4):612-7. PubMed ID: 3994157
[TBL] [Abstract][Full Text] [Related]
42. Anchoring fibrils. A new connective tissue structure in fibrotic lung disease.
Kawanami O; Ferrans VJ; Roberts WC; Crystal RG; Fulmer JD
Am J Pathol; 1978 Aug; 92(2):389-410. PubMed ID: 677268
[TBL] [Abstract][Full Text] [Related]
43. Collagenase in the lower respiratory tract of patients with idiopathic pulmonary fibrosis.
Gadek JE; Kelman JA; Fells G; Weinberger SE; Horwitz AL; Reynolds HY; Fulmer JD; Crystal RG
N Engl J Med; 1979 Oct; 301(14):737-42. PubMed ID: 225666
[TBL] [Abstract][Full Text] [Related]
44. Lung disease associated with progressive systemic sclerosis. Assessment of interlobar variation by bronchoalveolar lavage and comparison with noninvasive evaluation of disease activity.
Miller KS; Smith EA; Kinsella M; Schabel SI; Silver RM
Am Rev Respir Dis; 1990 Feb; 141(2):301-6. PubMed ID: 2301848
[TBL] [Abstract][Full Text] [Related]
45. Fibrosing alveolitis in systemic sclerosis. Bronchoalveolar lavage findings in relation to computed tomographic appearance.
Wells AU; Hansell DM; Rubens MB; Cullinan P; Haslam PL; Black CM; Du Bois RM
Am J Respir Crit Care Med; 1994 Aug; 150(2):462-8. PubMed ID: 8049830
[TBL] [Abstract][Full Text] [Related]
46. [Latent alveolitis in systemic disease. The transition between the normal and the pathological].
Wallaert B; Dugas M; Tonnel AB; Voisin C
Rev Mal Respir; 1990; 7(1):17-25. PubMed ID: 2251429
[TBL] [Abstract][Full Text] [Related]
47. [Possible connection between gastroesophageal reflux and interstitial pulmonary fibrosis in patients with systemic sclerosis].
Savarino E; Ghio M; Marabotto E; Zentilin P; Sammito G; Cittadini G; Sconfienza L; Murolo C; Gemignani L; Indiveri F; Savarino V
Recenti Prog Med; 2009 Nov; 100(11):512-6. PubMed ID: 20066883
[TBL] [Abstract][Full Text] [Related]
48. Pulmonary functions in children with progressive systemic sclerosis.
Garty BZ; Athreya BH; Wilmott R; Scarpa N; Doughty R; Douglas SD
Pediatrics; 1991 Dec; 88(6):1161-7. PubMed ID: 1956732
[TBL] [Abstract][Full Text] [Related]
49. Interstitial lung disease in scleroderma. Analysis by bronchoalveolar lavage.
Silver RM; Metcalf JF; Stanley JH; LeRoy EC
Arthritis Rheum; 1984 Nov; 27(11):1254-62. PubMed ID: 6497920
[TBL] [Abstract][Full Text] [Related]
50. Regional differences in bronchoalveolar lavage and thoracic high-resolution computed tomography results in dyspneic patients with systemic sclerosis.
Clements PJ; Goldin JG; Kleerup EC; Furst DE; Elashoff RM; Tashkin DP; Roth MD
Arthritis Rheum; 2004 Jun; 50(6):1909-17. PubMed ID: 15188367
[TBL] [Abstract][Full Text] [Related]
51. Subclinical pulmonary involvement in collagen-vascular diseases assessed by bronchoalveolar lavage. Relationship between alveolitis and subsequent changes in lung function.
Wallaert B; Hatron PY; Grosbois JM; Tonnel AB; Devulder B; Voisin C
Am Rev Respir Dis; 1986 Apr; 133(4):574-80. PubMed ID: 3963625
[TBL] [Abstract][Full Text] [Related]
52. Gallium-67 citrate scanning in the staging of idiopathic pulmonary fibrosis: Correlation and physiologic and morphologic features and bronchoalveolar lavage.
Line BR; Fulmer JD; Reynolds HY; Roberts WC; Jones AE; Harris EK; Crystal RG
Am Rev Respir Dis; 1978 Aug; 118(2):355-65. PubMed ID: 697186
[TBL] [Abstract][Full Text] [Related]
53. Characteristics of pulmonary inflammation in combined pulmonary fibrosis and emphysema.
Zhao Y; Cui A; Wang F; Wang XJ; Chen X; Jin ML; Huang KW
Chin Med J (Engl); 2012 Sep; 125(17):3015-21. PubMed ID: 22932172
[TBL] [Abstract][Full Text] [Related]
54. [Analysis by broncho-alveolar lavage of the pulmonary uptake of gallium 67 in idiopathic diffuse interstitial fibrosis and sarcoidosis].
Vergnon JM; Lahneche B; Ripoll JP; Pages J; Chauvot P; Brune J
Rev Mal Respir; 1987; 4(2):85-93. PubMed ID: 3589113
[TBL] [Abstract][Full Text] [Related]
55. Pulmonary involvement in diffuse cutaneous systemic sclerosis: broncheoalveolar fluid granulocytosis predicts progression of fibrosing alveolitis.
Witt C; Borges AC; John M; Fietze I; Baumann G; Krause A
Ann Rheum Dis; 1999 Oct; 58(10):635-40. PubMed ID: 10491363
[TBL] [Abstract][Full Text] [Related]
56. A controlled clinicopathologic study of myocardial fibrosis in systemic sclerosis (scleroderma).
Follansbee WP; Miller TR; Curtiss EI; Orie JE; Bernstein RL; Kiernan JM; Medsger TA
J Rheumatol; 1990 May; 17(5):656-62. PubMed ID: 2359076
[TBL] [Abstract][Full Text] [Related]
57. Bronchoalveolar lavage in patients with interstitial lung diseases: side effects and factors affecting fluid recovery.
Dhillon DP; Haslam PL; Townsend PJ; Primett Z; Collins JV; Turner-Warwick M
Eur J Respir Dis; 1986 May; 68(5):342-50. PubMed ID: 3732429
[TBL] [Abstract][Full Text] [Related]
58. Increased uptake of 111In-octreotide in idiopathic pulmonary fibrosis.
Lebtahi R; Moreau S; Marchand-Adam S; Debray MP; Brauner M; Soler P; Marchal J; Raguin O; Gruaz-Guyon A; Reubi JC; Le Guludec D; Crestani B
J Nucl Med; 2006 Aug; 47(8):1281-7. PubMed ID: 16883006
[TBL] [Abstract][Full Text] [Related]
59. Severity of scleroderma lung disease is related to alveolar concentration of nitric oxide.
Tiev KP; Cabane J; Aubourg F; Kettaneh A; Ziani M; Mouthon L; Duong-Quy S; Fajac I; Guillevin L; Dinh-Xuan AT
Eur Respir J; 2007 Jul; 30(1):26-30. PubMed ID: 17428812
[TBL] [Abstract][Full Text] [Related]
60. Assessment of interlobar variation of bronchoalveolar lavage cellular differentials in interstitial lung diseases.
Garcia JG; Wolven RG; Garcia PL; Keogh BA
Am Rev Respir Dis; 1986 Mar; 133(3):444-9. PubMed ID: 3954253
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
